{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:50:53Z","timestamp":1790704253510,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700560"],"award-info":[{"award-number":["81700560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1889-0","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T14:04:23Z","timestamp":1556805863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Meng-yun","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-3829","authenticated-orcid":false,"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"issue":"2","key":"1889_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1889_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00000658-200107000-00011","volume":"234","author":"GL Grazi","year":"2001","unstructured":"Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, Mazziotti A. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234(1):71\u20138.","journal-title":"Ann Surg"},{"issue":"6","key":"1889_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, Ma L, Qi LN, Ou BN, Li LQ. Albumin\u2013bilirubin versus Child\u2013Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(6):725\u201334.","journal-title":"Br J Surg"},{"issue":"5","key":"1889_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ejso.2016.02.009","volume":"42","author":"J Dong","year":"2016","unstructured":"Dong J, Xu XH, Ke MY, Xiang JX, Liu WY, Liu XM, Wang B, Zhang XF, Lv Y. The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria. Eur J Surg Oncol. 2016;42(5):722\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1889_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/00000658-199902000-00008","volume":"229","author":"O Farges","year":"1999","unstructured":"Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229(2):210\u20135.","journal-title":"Ann Surg"},{"issue":"1","key":"1889_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00000658-199901000-00011","volume":"229","author":"N Nagasue","year":"1999","unstructured":"Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child\u2013Turcotte class B and C cirrhosis. Ann Surg. 1999;229(1):84\u201390.","journal-title":"Ann Surg"},{"issue":"6","key":"1889_CR7","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1053\/jhep.2002.32525","volume":"35","author":"RD Kladney","year":"2002","unstructured":"Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002;35(6):1431\u201340.","journal-title":"Hepatology"},{"issue":"6","key":"1889_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2005.05.028","volume":"43","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D\u2019Amelio A, Lok AS, Block TM. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol. 2005;43(6):1007\u201312.","journal-title":"J Hepatol"},{"issue":"3","key":"1889_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1073\/pnas.0408928102","volume":"102","author":"TM Block","year":"2005","unstructured":"Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA. 2005;102(3):779\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1889_CR10","doi-asserted-by":"publisher","first-page":"e53862","DOI":"10.1371\/journal.pone.0053862","volume":"8","author":"H Wei","year":"2013","unstructured":"Wei H, Li B, Zhang R, Hao X, Huang Y, Qiao Y, Hou J, Li X, Li X. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections. PLoS ONE. 2013;8(2):e53862.","journal-title":"PLoS ONE"},{"issue":"16\u201317","key":"1889_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clinbiochem.2014.08.010","volume":"47","author":"Y Qiao","year":"2014","unstructured":"Qiao Y, Chen J, Li X, Wei H, Xiao F, Chang L, Zhang R, Hao X, Wei H. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection. Clin Biochem. 2014;47(16\u201317):216\u201322.","journal-title":"Clin Biochem"},{"issue":"6","key":"1889_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O\u2019Beirne J, Fox R, Skowronska A, Palmer D, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1889_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hep.27654","volume":"61","author":"B Suh","year":"2015","unstructured":"Suh B, Park S, Shin DW, Yun JM, Yang HK, Yu SJ, Shin CI, Kim JS, Ahn E, Lee H, et al. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology. 2015;61(4):1261\u20138.","journal-title":"Hepatology"},{"issue":"1","key":"1889_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.22576","volume":"49","author":"S Naveau","year":"2009","unstructured":"Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y, Munteanu M, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009;49(1):97\u2013105.","journal-title":"Hepatology"},{"issue":"2","key":"1889_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"3\u20134","key":"1889_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2119\/molmed.2008.00110","volume":"15","author":"VR Mas","year":"2009","unstructured":"Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med. 2009;15(3\u20134):85\u201394.","journal-title":"Mol Med"},{"issue":"5","key":"1889_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.surg.2007.05.009","volume":"142","author":"K Taura","year":"2007","unstructured":"Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery. 2007;142(5):685\u201394.","journal-title":"Surgery"},{"issue":"2","key":"1889_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.27841","volume":"62","author":"H Huang","year":"2015","unstructured":"Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, Wang S, Kim J, Billiar T, Wang Y, et al. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology. 2015;62(2):600\u201314.","journal-title":"Hepatology"},{"issue":"2","key":"1889_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0168-8278(97)80185-7","volume":"27","author":"M Kaibori","year":"1997","unstructured":"Kaibori M, Kwon AH, Nakagawa M, Wei T, Uetsuji S, Kamiyama Y, Okumura T, Kitamura N. Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocyte growth factor. J Hepatol. 1997;27(2):381\u201390.","journal-title":"J Hepatol"},{"issue":"2","key":"1889_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0002-9440(10)64881-X","volume":"160","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol. 2002;160(2):613\u201320.","journal-title":"Am J Pathol"},{"issue":"2","key":"1889_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.27129","volume":"60","author":"K Kazankov","year":"2014","unstructured":"Kazankov K, Barrera F, Moller HJ, Bibby BM, Vilstrup H, George J, Gronbaek H. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology. 2014;60(2):521\u201330.","journal-title":"Hepatology"},{"issue":"1","key":"1889_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61(1):292\u2013302.","journal-title":"Hepatology"},{"issue":"6","key":"1889_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/hep.21420","volume":"44","author":"N Ganne-Carrie","year":"2006","unstructured":"Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, Dhumeaux D, Trinchet JC, Beaugrand M. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44(6):1511\u20137.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"1889_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jvh.12786","volume":"24","author":"Z Cao","year":"2017","unstructured":"Cao Z, Li Z, Wang Y, Liu Y, Mo R, Ren P, Chen L, Lu J, Li H, Zhuang Y, et al. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. J Viral Hepatitis. 2017;24(Suppl 1):57\u201365.","journal-title":"J Viral Hepatitis"},{"issue":"5","key":"1889_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/jgh.13250","volume":"31","author":"A Hiraoka","year":"2016","unstructured":"Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, et al. Usefulness of albumin\u2013bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2016;31(5):1031\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1889_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, Jang JW, Smirne C, Kim YW, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66(2):338\u201346.","journal-title":"J Hepatol"},{"issue":"7","key":"1889_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/bjc.2016.33","volume":"114","author":"H Toyoda","year":"2016","unstructured":"Toyoda H, Lai PB, O\u2019Beirne J, Chong CC, Berhane S, Reeves H, Manas D, Fox RP, Yeo W, Mo F, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114(7):744\u201350.","journal-title":"Br J Cancer"},{"issue":"12","key":"1889_CR28","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1136\/gut.2010.214916","volume":"59","author":"Y Mao","year":"2010","unstructured":"Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, Zhao H, Chen W, Xu Y, Chi T, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010;59(12):1687\u201393.","journal-title":"Gut"},{"issue":"3","key":"1889_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jgh.12461","volume":"29","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y. Golgi protein 73, not glypican-3, may be a tumor marker complementary to alpha-Fetoprotein for hepatocellular carcinoma diagnosis. J Gastroenterol Hepatol. 2014;29(3):597\u2013602.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1889_CR30","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/1055-9965.EPI-08-0980","volume":"18","author":"M Wang","year":"2009","unstructured":"Wang M, Long RE, Comunale MA, Junaidi O, Marrero J, Di Bisceglie AM, Block TM, Mehta AS. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomark Prev. 2009;18(6):1914\u201321.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"1889_CR31","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.18632\/oncotarget.14954","volume":"8","author":"T Liu","year":"2017","unstructured":"Liu T, Yao M, Liu S, Wang L, Wang L, Hou J, Ma X, Jia J, Zhao J, Zhuang H, et al. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma. Oncotarget. 2017;8(10):16498\u2013506.","journal-title":"Oncotarget"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1889-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T22:41:41Z","timestamp":1607553701000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1889-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1889-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"140"}}